TLDR : Starting in September, Wolters Kluwer will deploy UpToDate Enterprise Edition, an AI-enhanced software solution, in several major hospitals in France and Belgium. This platform aims to improve the quality of care and support medical teams by providing validated and contextualized information, facilitating clinical decision-making.
Table of contents
Starting in September, Wolters Kluwer, one of the world's leading providers of software solutions and expert information, will begin the deployment of UpToDate Enterprise Edition in several major hospitals in France and Belgium. Designed to meet the growing demands of clinical practice, this AI-enhanced version aims to improve the quality of care while providing tangible support to medical teams.
Originally created in the 1990s by Dr. Burton Rose, an American nephrologist, UpToDate was intended to allow doctors to make quick decisions in clinical situations by relying on a reliable and evidence-based resource, without the need to consult multiple publications.
Since its acquisition by the Dutch company Wolters Kluwer in 2008 as part of strengthening its health division, the platform has seen continuous expansion. It now boasts over 2 million users in 191 countries, in both primary care and hospital settings. This global positioning, supported by a constantly updated document corpus, has made UpToDate one of the reference tools for clinical decision support (CDS).
UpToDate Enterprise Edition: A New Technological Milestone
In a context marked by the increasing complexity of care pathways, the rapid evolution of protocols, and growing pressure on human resources, medical decision-making is becoming a more demanding task. Quick access to validated, contextualized information that is interoperable with hospital systems stands as a lever for clinical performance, as well as a factor supporting the well-being of healthcare professionals.
Designed for large institutions, territorial hospital groups (GHT), and integrated health systems, UpToDate Enterprise Edition fits into this dynamic.
Since 2024, Wolters Kluwer has been integrating GenAI components into its platform. The new version combines natural language search, intelligent analytics, and unified access to a validated medical knowledge base. The goal is not simply to facilitate documentary research but to enhance the safety, speed, and relevance of clinical decision-making while reducing cognitive load for caregivers.
The solution also offers actionable usage indicators at the institutional level, enabling the direction of continuing education, identifying specific needs of certain specialties, and better targeting practices for harmonization.
An International Dynamic and Promising Feedback
Already adopted by more than 350 institutions in North America, UpToDate Enterprise Edition is currently being deployed in about forty major hospitals in the EMEA region. Initial feedback highlights improved interdisciplinary collaboration, better fluidity in complex decision-making, and valuable support for clinical teaching.
In Iceland, as in the United Kingdom, healthcare professionals describe a paradigm shift: less time spent searching for information, more capacity to focus on the quality of the caregiver-patient relationship.
Translated from Réinventer la décision clinique avec l’IA : Wolters Kluwer déploie UpToDate Enterprise en France et en Belgique
To better understand
What is GenAI and how does it enhance the UpToDate Enterprise Edition platform?
GenAI, or Generative Artificial Intelligence, is a technology that generates content from data, enhancing UpToDate Enterprise Edition with natural language searches and intelligent analytics to improve the relevance of clinical decisions.
What are the regulatory frameworks in Europe that could influence the use of a platform like UpToDate Enterprise Edition?
Regulatory frameworks in Europe, such as the General Data Protection Regulation (GDPR) and medical device directives, can influence the use of digital platforms by requiring strict data privacy and security standards.